Nutra Pharma to Present at Upcoming Investment Conference
19 November 2013 - 6:38AM
Marketwired
Nutra Pharma to Present at Upcoming Investment Conference
Nutra Pharma Is Announcing That They Will Present at the
Upcoming Undiscovered Equities Conference in Boca Raton, Florida on
Thursday, November 21, 2013
CORAL SPRINGS, FL--(Marketwired - Nov 18, 2013) - Nutra Pharma
Corp. (OTCQB: NPHC), a biotechnology company that is developing
treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple
Sclerosis (MS), will be presenting at the upcoming Undiscovered
Equities Conference in Boca Raton, Florida on Thursday, November
21, 2013. The presentation will be made by the Company's CEO, Rik J
Deitsch, who will be providing updates on the sales and marketing
activities for the Company's over-the-counter (OTC) pain relievers;
Nyloxin®, Pet Pain-Away, Cobroxin® and Equine
Nyloxin®.
"This conference provides an excellent opportunity to expand our
presence within the investment community and share our unique and
exciting growth story," commented Rik J Deitsch, CEO of Nutra
Pharma. "We first presented at the Undiscovered Equities
Conferences in 2009 when we launched our first retail product,
Cobroxin. That conference created a lot of excitement among our
investors and we hope to emulate that at this and future
conferences," he concluded.
Undiscovered Equities is a provider of equity research on
high-impact aggressive growth investment opportunities. Their
services include research analysis on the energy and precious
metals markets, news and financial data, market commentary and the
Undiscovered Equities newsletter. Their Fall Conference includes a
full day of presentations at Ruth's Chris Steakhouse in Boca Raton,
Florida on November 21, 2013 from 8:30am through 4:00pm followed by
a nighttime reception. Nutra Pharma is scheduled to present at
approximately 10:30am. For more information on Undiscovered
Equities, visit: http://undiscoveredequities.com
Nutra Pharma recently announced the expansion of marketing and
distribution of their Nyloxin® products, the re-launch of Cobroxin®
as well as the initial launch of Pet Pain-Away for pain in
companion animals and Equine Nyloxin® for pain in horses.
The Company is looking forward to the expanded marketing campaign
for Nyloxin® by their distributor, New Vitality and the launch of
the first Nyloxin® television commercials by the end of the
year.
About Nutra Pharma Corp. Nutra Pharma Corporation operates as a
biotechnology company specializing in the acquisition, licensing,
and commercialization of pharmaceutical products and technologies
for the management of neurological disorders, cancer, autoimmune,
and infectious diseases, including Multiple Sclerosis (MS), Human
Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain.
Additionally, the Company markets several drug products for sale
for the treatment of pain under the brands Cobroxin® and Nyloxin®.
For additional information about Nutra Pharma, visit:
http://www.NutraPharma.com or http://www.Nyloxin.com.
SEC Disclaimer This press release contains forward-looking
statements. The words or phrases "would be," "will allow," "intends
to," "will likely result," "are expected to," "will continue," "is
anticipated," "estimate," "project," or similar expressions are
intended to identify "forward-looking statements." Actual results
could differ materially from those projected in Nutra Pharma's
("the Company") business plan. The presentation at this conference
should not be construed as an indication in any way whatsoever of
the future value of the Company's common stock or its financial
value. The Company's filings may be accessed at the SEC's Edgar
system at www.sec.gov. Statements made herein are as of the date of
this press release and should not be relied upon as of any
subsequent date. The Company cautions readers not to place reliance
on such statements. Unless otherwise required by applicable law, we
do not undertake, and we specifically disclaim any obligation, to
update any forward-looking statements to reflect occurrences,
developments, unanticipated events or circumstances after the date
of such statement.
Nutra Pharma (CE) (USOTC:NPHC)
Historical Stock Chart
From Apr 2024 to May 2024
Nutra Pharma (CE) (USOTC:NPHC)
Historical Stock Chart
From May 2023 to May 2024